Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 56

    1.

    Priming and Activation of Human Ovarian and Breast Cancer-specific CD8+ T Cells by Polyvalent Listeria monocytogenes-based Vaccines.

    Sinnathamby G, Lauer P, Zerfass J, Hanson B, Karabudak A, Krakover J, Secord AA, Clay TM, Morse MA, Dubensky TW Jr, Brockstedt DG, Philip R, Giedlin M.

    J Immunother. 2009 Sep 11. [Epub ahead of print]PMID: 19752748 [PubMed - as supplied by publisher]Related articles

    2.

    Suppression of cell-mediated immunity following recognition of phagosome-confined bacteria.

    Bahjat KS, Meyer-Morse N, Lemmens EE, Shugart JA, Dubensky TW, Brockstedt DG, Portnoy DA.

    PLoS Pathog. 2009 Sep;5(9):e1000568. Epub 2009 Sep 4.PMID: 19730694 [PubMed - in process]Related articlesFree article

    3.

    Impact of preexisting vector-specific immunity on vaccine potency: characterization of listeria monocytogenes-specific humoral and cellular immunity in humans and modeling studies using recombinant vaccines in mice.

    Leong ML, Hampl J, Liu W, Mathur S, Bahjat KS, Luckett W, Dubensky TW Jr, Brockstedt DG.

    Infect Immun. 2009 Sep;77(9):3958-68. Epub 2009 Jun 15.PMID: 19528221 [PubMed - indexed for MEDLINE]Related articles

    4.

    Killed but metabolically active Bacillus anthracis vaccines induce broad and protective immunity against anthrax.

    Skoble J, Beaber JW, Gao Y, Lovchik JA, Sower LE, Liu W, Luckett W, Peterson JW, Calendar R, Portnoy DA, Lyons CR, Dubensky TW Jr.

    Infect Immun. 2009 Apr;77(4):1649-63. Epub 2009 Jan 21.PMID: 19168734 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    KBMA Listeria monocytogenes is an effective vector for DC-mediated induction of antitumor immunity.

    Skoberne M, Yewdall A, Bahjat KS, Godefroy E, Lauer P, Lemmens E, Liu W, Luckett W, Leong M, Dubensky TW, Brockstedt DG, Bhardwaj N.

    J Clin Invest. 2008 Dec;118(12):3990-4001. doi: 10.1172/JCI31350. Epub 2008 Nov 6.PMID: 19033668 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    KBMA Listeria monocytogenes is an effective vector for DC-mediated induction of antitumor immunity.

    Skoberne M, Yewdall A, Bahjat KS, Godefroy E, Lauer P, Lemmens E, Liu W, Luckett W, Leong M, Dubensky TW, Brockstedt DG, Bhardwaj N.

    J Clin Invest. 2008 Nov 6. [Epub ahead of print]PMID: 18989377 [PubMed - as supplied by publisher]Related articlesFree article

    7.

    Promises and challenges for the development of Listeria monocytogenes-based immunotherapies.

    Brockstedt DG, Dubensky TW.

    Expert Rev Vaccines. 2008 Sep;7(7):1069-84. Review.PMID: 18767955 [PubMed - indexed for MEDLINE]Related articles

    8.

    Listeria monocytogenes multidrug resistance transporters activate a cytosolic surveillance pathway of innate immunity.

    Crimmins GT, Herskovits AA, Rehder K, Sivick KE, Lauer P, Dubensky TW Jr, Portnoy DA.

    Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):10191-6. Epub 2008 Jul 16.PMID: 18632558 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Constitutive Activation of the PrfA regulon enhances the potency of vaccines based on live-attenuated and killed but metabolically active Listeria monocytogenes strains.

    Lauer P, Hanson B, Lemmens EE, Liu W, Luckett WS, Leong ML, Allen HE, Skoble J, Bahjat KS, Freitag NE, Brockstedt DG, Dubensky TW Jr.

    Infect Immun. 2008 Aug;76(8):3742-53. Epub 2008 Jun 9.PMID: 18541651 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Plasmid DNA-based alphavirus expression vectors for nucleic acid immunization.

    Driver DA, Polo JM, Belli BA, Banks TA, Hariharan M, Dubensky TW Jr.

    IDrugs. 1998 Oct;1(6):678-85.PMID: 18465622 [PubMed - in process]Related articles

    11.

    Activation of immature hepatic NK cells as immunotherapy for liver metastatic disease.

    Bahjat KS, Prell RA, Allen HE, Liu W, Lemmens EE, Leong ML, Portnoy DA, Dubensky TW Jr, Brockstedt DG, Giedlin MA.

    J Immunol. 2007 Dec 1;179(11):7376-84.PMID: 18025181 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Inactivation of parvovirus B19 in human platelet concentrates by treatment with amotosalen and ultraviolet A illumination.

    Sawyer L, Hanson D, Castro G, Luckett W, Dubensky TW Jr, Stassinopoulos A.

    Transfusion. 2007 Jun;47(6):1062-70.PMID: 17524098 [PubMed - indexed for MEDLINE]Related articles

    13.

    Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells.

    Goldberg MV, Maris CH, Hipkiss EL, Flies AS, Zhen L, Tuder RM, Grosso JF, Harris TJ, Getnet D, Whartenby KA, Brockstedt DG, Dubensky TW Jr, Chen L, Pardoll DM, Drake CG.

    Blood. 2007 Jul 1;110(1):186-92. Epub 2007 Mar 28.PMID: 17392506 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Cytosolic entry controls CD8+-T-cell potency during bacterial infection.

    Bahjat KS, Liu W, Lemmens EE, Schoenberger SP, Portnoy DA, Dubensky TW Jr, Brockstedt DG.

    Infect Immun. 2006 Nov;74(11):6387-97. Epub 2006 Sep 5.PMID: 16954391 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity.

    Chan CW, Crafton E, Fan HN, Flook J, Yoshimura K, Skarica M, Brockstedt D, Dubensky TW, Stins MF, Lanier LL, Pardoll DM, Housseau F.

    Nat Med. 2006 Feb;12(2):207-13. Epub 2006 Jan 29.PMID: 16444266 [PubMed - indexed for MEDLINE]Related articles

    16.

    Selective targeting of antitumor immune responses with engineered live-attenuated Listeria monocytogenes.

    Yoshimura K, Jain A, Allen HE, Laird LS, Chia CY, Ravi S, Brockstedt DG, Giedlin MA, Bahjat KS, Leong ML, Slansky JE, Cook DN, Dubensky TW, Pardoll DM, Schulick RD.

    Cancer Res. 2006 Jan 15;66(2):1096-104.PMID: 16424046 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Killed but metabolically active microbes: a new vaccine paradigm for eliciting effector T-cell responses and protective immunity.

    Brockstedt DG, Bahjat KS, Giedlin MA, Liu W, Leong M, Luckett W, Gao Y, Schnupf P, Kapadia D, Castro G, Lim JY, Sampson-Johannes A, Herskovits AA, Stassinopoulos A, Bouwer HG, Hearst JE, Portnoy DA, Cook DN, Dubensky TW Jr.

    Nat Med. 2005 Aug;11(8):853-60. Epub 2005 Jul 24.PMID: 16041382 [PubMed - indexed for MEDLINE]Related articles

    18.

    Enhanced potency of plasmid DNA microparticle human immunodeficiency virus vaccines in rhesus macaques by using a priming-boosting regimen with recombinant proteins.

    Otten GR, Schaefer M, Doe B, Liu H, Srivastava I, Megede J, Kazzaz J, Lian Y, Singh M, Ugozzoli M, Montefiori D, Lewis M, Driver DA, Dubensky T, Polo JM, Donnelly J, O'Hagan DT, Barnett S, Ulmer JB.

    J Virol. 2005 Jul;79(13):8189-200.PMID: 15956564 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Listeria-based cancer vaccines that segregate immunogenicity from toxicity.

    Brockstedt DG, Giedlin MA, Leong ML, Bahjat KS, Gao Y, Luckett W, Liu W, Cook DN, Portnoy DA, Dubensky TW Jr.

    Proc Natl Acad Sci U S A. 2004 Sep 21;101(38):13832-7. Epub 2004 Sep 13.PMID: 15365184 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Listeria monocytogenes as a vaccine vector: virulence attenuation or existing antivector immunity does not diminish therapeutic efficacy.

    Starks H, Bruhn KW, Shen H, Barry RA, Dubensky TW, Brockstedt D, Hinrichs DJ, Higgins DE, Miller JF, Giedlin M, Bouwer HG.

    J Immunol. 2004 Jul 1;173(1):420-7.PMID: 15210801 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...